Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
Clinical trial NCT02074982 · COMPLETED
Trial details
- NCT number
- NCT02074982
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-26
- Primary completion
- 2016-06-29
- Enrollment
- 676
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.